Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Lymphoma, Non-Hodgkin × Pharmaceutical Preparations × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Head and Neck Neoplasms 3 Carcinoma, Hepatocellular 3 Neoplasms 2 Melanoma 2 Lymphoma, B-Cell, Marginal Zone 2 Urinary Bladder Neoplasms 1 Sarcoma 1 Prostatic Neoplasms 1 NSCLC 1 Lymphoma, Non-Hodgkin 1 Lymphedema 1 Gynecological Cancers 1 Fibrosis 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Squamous Cell 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Ductal, Breast 1 Breast Neoplasms 1 BRAF V600 Colorectal Cancer 1 Anxiety Disorders 1 Adenomatous Polyposis Coli 1

Interventions

Cyclophosphamide 136 Rituximab 130 Etoposide 75 fludarabine phosphate 62 Peripheral Blood Stem Cell Transplantation 59 Busulfan 56 Mycophenolic Acid 55 Filgrastim 54 Melphalan 53 Tacrolimus 46 Whole-Body Irradiation 43 fludarabine 41 Radiotherapy 41 Cytarabine 40 Methotrexate 36 Cyclosporine 34 Granulocyte Colony-Stimulating Factor 33 Vincristine 31 Antilymphocyte Serum 31 Carmustine 29 Doxorubicin 25 Thiotepa 23 Prednisone 23 Bendamustine Hydrochloride 22 thymoglobulin 21 Methylprednisolone 20 Dexamethasone 19 Ifosfamide 18 sargramostim 16 plerixafor 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00596154 2024-04-01

PCNSL

Memorial Sloan Kettering Cancer Center

Phase 2 Completed

33 enrolled 9 charts

Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡